Is autoimmunity or insulin resistance the primary driver of type 1 diabetes?

Current Diabetes Reports

Volumn 13, Issue 5, 2013, Pages 651-656

  Wilkin, Terence J ^a,b  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Accelerator hypothesis; Autoimmunity; Insulin resistance; Pathophysiology; T1D; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN; INSULIN;

AGE; ARTICLE; AUTOIMMUNE REGULATOR GENE; AUTOIMMUNITY; BODY MASS; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IMMUNOREGULATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; WEIGHT GAIN;

AUTOIMMUNITY; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN RESISTANCE;

EID: 84884578219     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-013-0407-7     Document Type: Article

References (50)

1. Himsworth HP. Diabetes mellitus: Its differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1936;I:127-30.
2. Himsworth HP, Kerr RB. Insulin sensitive and insulin-insensitive types of diabetes mellitus. Clin Sci. 1939;4:119-52.
3. Martin FIR, Stocks AE. Insulin sensitivity and 131l-insulin metabolism in juvenile-type diabetics. Aust Ann Med. 1967;76:289-96.
4. Ginsberg HN. Investigation of insulin sensitivity in treated subjects with ketosis prone diabetes mellitus. Diabetes. 1977;26:278-83.
5. Harano Y, Ohgaku S, Hidaka H, Haneda K, Kikkawa R, Shigeta Y, et al. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab. 1977;45:1124-7.
6. Defronzo RA, Bendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes. 1982;37:795-801.
7. Joslin EP, Root HF, White P, et al. The treatment of diabetes mellitus. London: Henry Kimpton; 1947. p. 144-6.
8. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965;14:619-33.
9. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974;2:1279-83.
10. Nerup J et al. HLA antigens and diabetes mellitus. Lancet. 1974;2:864-6.
11. •• Bonifacio E. Immunotherapy in T1D: a shorter but more winding road? Diabetes. 2012;61:2214-5. A balanced and compelling appraisal of the difficulties that have met immunotherapy trials in their attempts to prevent T1D.
12. Gale EAM. Declassifying diabetes. Diabetologia. 2006;49:1989-95.
13. Wilkin TJ. The accelerator hypothesis: Weight gain as the missing link between Type I and Type II diabetes. Diabetologia. 2001;44:914-22.
14. von Herrath M, Nepom GT. Animal models of human type 1 diabetes. Nat Immunol. 2009;10:129-32.
15. Wilkin TJ. Changing perspectives in diabetes: their impact on its classification. Diabetologia. 2007;50:1587-92.
16. Reinehr T, Schober E, Wiegand S, et al. Beta-cell autoantibodies in children with type 2 diabetes mellitus: Subgroup or misclassification? Arch Dis Child. 2006;91:473-7.
17. Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a noninsulin-dependent onset of disease. Diabetes. 1993;42:359-62.
18. Molbak AG, Christau B, Marner B, et al. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabetic Med. 1994;11:650-5.
19. Baum JD, Ounsted M, Smith MA. Weight gain in infancy and subsequent development of diabetes mellitus in childhood. Lancet. 1975;2:866.
20. Keen H, Jarrett RJ. Environmental factors and genetic interactions. In: Creutzfeld W, Kobberling J, Neel JV, editors. The genetics of diabetes mellitus. Berlin: Springer-Verlag; 1976. p. 203-14.
21. Gale EAM. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51:3353-61.
22. Gottlieb MS. Diabetes in offspring and siblings of juvenile- and maturity-onset-type diabetics. J Chronic Dis. 1980;33:331-9.
23. Dahlquist G et al. The Swedish childhood diabetes study: results from a 9 year case register and a 1 year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (noninsulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia. 1989;32:2-6.
24. Wilkin TJ. Autoimmunity: attack, or defence? Autoimmunity. 1989;3:57-73.
25. Grabar P. Autoantibodies and the physiological role of immunoglobulins. Immunol Today. 1983;4:337-40.
26. Hypothesis GP. Auto-antibodies and immunological theories: an analytical review. Clin Immunol Immunopathol. 1975;4:453-66.
27. Basu R, Breda E, Oberg AL, et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribu
28. Costes F, Langen R, Gurlo T, et al. β-cell failure in type 2 diabetes: A case of asking too much of too few? Diabetes. 2013;62:327-35.
29. Patterson CC, Dahlquist GG, Gyürüs E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373:2027-33.
30. Maedler K et al. Glucose induces b-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes. 2001;50:1683-90.
31. Donath MY et al. Hyperglycaemia-induced β-cell apoptosis in pancreatic cells of Psammomys obesus during development of diabetes. Diabetes. 1999;48:738-44.
32. Robertson RP et al. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53 Suppl 1:S119-24.
33. Johansson C et al. A high weight gain in early life is associated with an increased risk of type 1(insulin-dependent) diabetes. Diabetologia. 1994;37:91-4.
34. Hypponen E et al. Infant feeding, early weight gain and risk of type 1 diabetes. Diabetes Care. 1999;22:1961-5.
35. Bruining GJ. Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet. 2000;356:655-6.
36. • Harder T et al. Birth weight, early weight gain, and subsequent risk of type 1 diabetes: Systematic review and meta-analysis. Am J Epidemiol. 2009;169:1428-36. The most comprehensive evidence available that children who develop T1D are heavier from early life than their peers who do not.
37. Wilkin TJ. The great weight gain experiment, accelerators, and their implications for autoantibodies in diabetes. Arch Dis Child. 2006;91:456-8.
38. Wilkin TJ. The accelerator hypothesis. In: Bantle JP, Slama G, editors. Nutritional management of diabetes mellitus and dysmetabolic syndrome. Karger: Nestle International Workshops; 2006. p. 139-53.
39. Wilkin TJ. Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis. Pediatric Diabetes. 2008;9:23-32.
40. Wilkin TJ. The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type 1 as well as type 2 diabetes. Int J Obesity. 2009;33(7):16-26.
41. • Wilkin TJ. The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis. Pediatric Diabetes. 2012;13:334-9. The most recent update of the accelerator hypothesis and the role of insulin resistance in T1D.
42. Hermann R, Knip M, Veijola R. Temporal changes in the frequencies of HLA genotypes in patients with type I diabetes - indication of an increased environmental pressure? Diabetologia. 2003;46:420-5.
43. Gillespie KM, Bain SC, Barnett AH. The rising incidence of type 1 diabetes is associated with a reduced contribution from high-risk HLA haplotypes. Lancet. 2004;364:1699-700.
44. Dabelea D, D'Agostino Jr RB, Mayer-Davis EJ. SEARCH for Diabetes in Youth Study Group. Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care. 2006;29:290-4.
45. Bingley PJ, Mahon JL, Gale EA. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care. 2008;3:146-50.
46. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997;17:399-403.
47. Meloni A, Willcox N, Meager A, et al. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab. 2012;97:1114-24.
48. Turunen JA, Wessman M, Forsblom C, et al. Association analysis of the AIRE and insulin genes in Finnish type 1 diabetic patients. Immunogenetics. 2006;58:331-8.
49. Wilkin TJ, Ludvigsson J, Greenbaum CJ, Palmer JP, Becker DJ, Bruining J. Future trials for the prevention of type 1 diabetes. Diabetes Care. 2004;27:996-7.
50. Wilkin TJ. The great weight gain experiment, accelerators and their implications for autoantibodies in diabetes. Arch Disease in Childhood. 2006;91:456-8.